Article
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer - 1 Oct 2012
Kutny Matthew A, Moser Barry K, Laumann Kristina, Feusner James H, Gamis Alan, Gregory John, Larson Richard A, Powell Bayard L, Stock Wendy, Willman Cheryl L, Woods William G, Meshinchi Soheil
Abstract excerpt
BACKGROUND: FLT3 mutations (FLT3/Mut) are prevalent in de novo AML and are associated with early relapse. The prevalence and prognostic significance of FLT3/Mut have not been well defined in childhood acute promyelocytic leukemia (APL). PROCEDURE: Diagnostic specimens from 104 pediatric APL patients were screened for FLT3/Mut (FLT3/ITD or FLT3/ALM). FLT3/Mut status was correlated with disease characteristics and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
